Pharmseal is a software company that aims to disrupt clinical trial management. The company claims that companies typically use multiple applications for managing clinical trials from one or more vendors. This increases cost and complexity. Pharmaseal asserts that its cloud Business-2-Business (B2B) platform, Engility, simplifies control by providing a single management portal. The platform allows information to be centralised and accessed from a single platform. Pharmaseal claims that Engility will allow companies to save cost and time and enable them to bring life-saving drugs to market faster. The company will utilise 31% of the investment for commercialisation and marketing, 49% for product development, 13% for IT infrastructure, and 7% for administrative/legal/miscellaneous activities.
days to go:
Expired
investment:
£532,311
Alter Vego (AV) aims to create an extensive range of plant-based, customisable supplements. The company asserts that its production process is sustainable. It starts by creating a vegan protein base blend from ingredients such as pea, hemp, quinoa and brown rice that is ethically sourced and produced. It then develops daily sachets that contain Omega 3, B12, D3, K1, digestive enzymes, and probiotics to complement the base blend. AV argues that the sachets provide 100% of a user's Recommended Dietary Allowance (RDA) over any pre-mixed bulk blend. It aspires to become a contender in the global nutrition sector worth $702 billion. AV will use the investment for manufacturing and marketing its products across the UK.
days to go:
Expired
investment:
£46,455
Cranes Drinks is the fastest growing cider company in the UK, producing a range of innovative fruit ciders. By utilising the fruit’s natural sweetness, its drinks contain 30% fewer calories compared to that of brand leaders. Cranes ciders come in 3 flavours: blueberry & apple, cranberry & lime, and raspberry & pomegranate. As per Cranes, 34% of cider drinkers haven't consumed cider drinks much because it’s too sweet or has too much sugar. This makes Cranes a top contender in a growing fruit cider market worth £1.3 billion. The company's entire range is available on Ocado, and it has received 3 national listings in prominent retail chains like Sainsbury’s, Asda, and Morrisons. The brand has won 3 awards for its spirit range including a Gold Award in the Liqueur Masters organised by The Spirits Business and two awards from the International Wine & Spirits Competition. It has also received substantial media coverage in publications like Made In Chelsea, Dragons Dens, The Daily Telegraph, The Evening Standard, Vogue, Cosmopolitan, and Bella amongst others. With the investment, the company aims to use 25% of it as working capital, 60% in marketing, and 15% in managing key finances.
days to go:
Expired
investment:
£246,046
Ayoa by OpenGenius is an intelligent digital workspace for remote teams to manage meetings, build plans and action tasks. Launched in June 2019, Ayoa already has over 12,000 paying users and c. 300,000 users who have signed up for the free product. Ayoa is used by many people at reputable organisations such as the BBC, Ernst & Young, and Cambridge University. It has an average customer rating of 4.5 stars from 1,000+ reviews across the Apple App Store, Google Play and Capterra. Moreover, the company's CEO, Chris Griffiths, has been featured in several publications such as the BBC, The Times, Forbes, GQ, and The Telegraph as an expert on topics such as creativity and productivity. With the funds received, the company will further develop its product by releasing newer features such as Smart Meetings, and Intelligent Digital Workspace, smoothening powerful integrations and integrating AI tools into the application.
days to go:
Expired
investment:
£1,143,029
POS8 is a company that has developed an app, Fetch, that allows customers to order and pay from their phone. The company feels that 'Fetch' holds prominence against the backdrop of the Covid-19 pandemic. Using the app, customers can view a menu, order food & drink and pay securely, all in a matter of seconds with no need for contact, from the comfort of their smartphones. The app's 'Intelligent Ordering System' sends orders to a venue staff’s own devices according to who has the fewest orders waiting. The company believes that its pay-per-transaction model allows it to dominate the £98 billion restaurants industry. POS8 is also developing a LIDAR (Light Detection and Ranging) & beacon location technology to pin-point guests to an accuracy of 10 cm for faster serving times. The company will use 10% of the investment to complete its location technology, 20% in Point of Sale (POS) integrations, 20% in operations, and 50% in sales and marketing to build customer and user base.
days to go:
Expired
investment:
£438,660
Burleighs Gin is a company that aims to establish itself as the leader in the gin market. It is the official gin partner for entities such as Leicester City Football Club, Leicester Tigers RFC, and the King Richard III foundation. Burleighs plans to introduce a 'non-alcoholic gin' apart from its gin products. The company feels that this will allow Burleighs to enter into the rapidly rising 'low & no' growth sector, now valued at £60 million a year in the UK. It also intends to commission the production of a 'Ready to Drink Gin & Tonic' in a can, another growth market driven by the popularity of gin that is now worth £472 million a year. Burleighs has on-trade listings secured with Cosy Club, Loungers, All Bar One, and Miller & Carter. It has hosted consumer events during 2019 including; Picnic in the Gardens, World Gin Day festival and The Great Burleighs Express. Burleighs Gin has been featured in BBC Good Food Guide's 'Best Gins to try in 2019'. They will use 50% of the investment for new product development, 15% for distillery expansion, 15% for recruitment drives, 10% for export growth, and 10% as marketing expenses.
days to go:
Expired
investment:
£130,490
Avida Global (AG) is a Business-to-Business (B2B) producer of high-quality medicinal cannabis oils and derivatives for the global medical, well-being and cosmeceutical markets. The company has a cultivation and processing facility in North-East Colombia. It asserts that the therapeutic properties of the cannabis plant has driven 53 countries to legalise its use, with more to follow. AG seeks to capture this demand and become a contender in the medicinal cannabis market that is expected to soar from $33.1 billion to $84.0 billion by 2028. The company has received regulatory approvals for initial non-psychoactive cannabis cultivation, manufacturing, and export licences in 2019. It is working on a partnership with a medicinal cannabis prescriber through doctors and clinics for the supply of medicinal cannabis strains in the UK. The company will use 40% of the investment to drive revenue growth, 25% as capital expenses, and 35% as additional operating expenses.
days to go:
Expired
investment:
£1,646,249
The Noo aims to redefine the delivery space by facilitating the delivery of anything, anywhere, anytime from a single application. It is on a mission to create a new micro-logistics delivery platform with no infrastructure needed besides a smartphone. The company also aspires to create a space where the local high street can compete with today's delivery giants. The Noo is backed by serial tech entrepreneur, Ant Sharp. The company has collected substantial data and insight, after 1.5 years of R&D and testing, to cater to the needs of its target audience and produce an app capable of changing the way things get delivered. It has also gained over 440 'Confirmation Of Interests' (COI) from potential investors willing to back the product. The Noo will use the investment to cover marketing costs, app development and maintenance costs, and general business running costs.
days to go:
Expired
investment:
£47,828
A premium British handcrafted candy-maker seeking funds to expand and grow their business internationally. In addition to their own candy and confectionary, they also offer customers to create their own designs using natural colourings and the finest ingredients. Spun Candy have the rights to the Candy Crush app.
days to go:
Expired
investment:
£341,990
RightIndem is a white-label insurance software platform designed to deliver fast claims to claimants on its portal. The company develops and sells its own proprietary cloud-based digital claim process management software ‘as a service’ to the global insurance market. Insurtech is a vast market and attracts large amounts of investment, with $4.36 billion invested in the first three quarters of 2019. Till date, it has contracted clients such as Axa XL, Archipelago, NN Belgium, NN Netherlands, and Mapfre, with engagements at various levels of implementation and progress in the UK, Italy, Peru, US, and South Africa. They have also earned regard for automating claims processes form some of the world’s largest insurance organizations allowing for the settlement of low to mid-value claims within hours instead of days or months. With the proceeds, the company will connect operating expenses to the point where client revenues from claim volumes match operating costs.
days to go:
Expired
investment:
£200,001
